Monograph Details

Immune System > Immunization
RECOMBIVAX HB PEDIATRIC/ADOLESCENT
Manufacturer
Merck & Co., Inc.
Legal Classification
Rx
Pharmacological Class
HB.
Generic Name
Hepatitis B surface antigen vaccine (recombinant) 5micrograms/0.5mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free.
Also
RECOMBIVAX HB ADULT
RECOMBIVAX HB DIALYSIS
Indications
Hepatitis B immunization.
Adults and Children
Use correct formulation; see literature. Give IM into anterolateral thigh for children; deltoid for adults. May give SC if risk of hemorrhage. Patients 0–19yrs of age (three-dose regimen): give 1st dose of 5micrograms at elected date and repeat after 1 month (2nd dose) and 6 months after first dose (3rd dose). Or, for patients 11–15yrs of age, may use alternate two-dose regimen: give 1st dose of 10micrograms at elected date and repeat after 4–6 months (2nd dose). Patients ≥20yrs of age: give 1st dose of 10micrograms at elected date and repeat after 1 month (2nd dose) and 6 months after first dose (3rd dose). Dialysis and pre-dialysis patients: give 1st dose of 40micrograms at elected date and repeat after 1 month (2nd dose) and 6 months after first dose (3rd dose); consider booster dose if antibody levels fall to <10mIU/mL). High-risk infants (mother is HBsAg positive or unknown) or if exposed to HBsAg: give hepatitis B immune globulin also (see literature).
Contraindications
Yeast hypersensitivity.
Precautions
Have epinephrine inj (1:1000) available. Serious active infection. Severely compromised cardiopulmonary status. Pregnancy (Cat.C). Nursing mothers.
Adverse Reactions
Local reactions, irritability, fatigue, headache, fever, malaise, nausea, diarrhea, anorexia, pharyngitis, upper respiratory infection, anaphylaxis.
How Supplied
Single-dose vials: Ped/Adolescent 5mcg/0.5mL (yellow cap)—1, 10
Adult 10mcg/1mL (green cap)—1, 10
Dialysis 40mcg/1mL (blue cap)—1
Additional Resources
Related Prescribing Note